Information for Authors
The Clinical Biochemist Reviews (Clin Biochem Rev) is published quarterly in print and electronically by the Australasian Association for Clinical Biochemistry and Laboratory Medicine (AACB). The Editor welcomes concise articles devoted to clinical biochemistry (chemical pathology, clinical chemistry) and its specialities including metabolic and molecular medicine.
The Clinical Biochemist Reviews publishes peer-reviewed articles which are detailed critical surveys and/or meta-analyses of previously published material relevant to clinical biochemistry (e.g. pathophysiology of disease, scientific methods, test interpretation and laboratory management including data handling and statistics). Suggested word count is 5,000–10,000, with generally more than 100 references. Shorter mini-reviews and commentaries are also welcome. The journal also publishes Guidelines, Guideline Reviews, Recommendations and Survey Reports, as well as the Proceedings of the Annual Scientific Meeting of the AACB. The Clinical Biochemist Reviews does not publish original research.
Unsolicited manuscripts are welcome. Prospective authors are advised to seek the Editor’s authorisation to avoid conflict with invited reviews. All enquiries regarding submissions should be directed to the Editor or the relevant member of the Editorial Team.
Editorial and Publishing Policies
The Clinical Biochemist Reviews uses a ‘single-blind’ peer review system, whereby reviewers will know the names of the authors, and their reviews will be returned to the authors in blinded format. At manuscript submission authors will be asked to suggest the names of experts who should be able to provide an objective peer review of their article. These reviewers should not be currently collaborating with the authors, or from the same institution as the authors. The Editor is not obliged to invite these suggested reviewers. If the Editor or Editorial Board member submits an article, this manuscript will be handled by an alternative Board member or Guest Editor.
Each manuscript received is treated confidentially, acknowledged, reviewed by the Editor, and then sent for peer review by at least two referees for review and mini-review articles and at least one referee for other article types. Authors are then advised of the acceptability of the manuscript for publication, generally within a few weeks of submission. Manuscripts accepted for publication are subject to copy editing, and galley proofs when available, are returned to the authors to review editorial changes and identify typesetting errors.
The corrected pdfs of the article are made immediately available on the AACB website, with access to full-text restricted to AACB members only. Articles are submitted subsequently to Open Access on PubMed Central.
Manuscript Submission
- Accuracy is the responsibility of the authors.
- Number in order of mention. Please superscript; do not use parentheses.
- Ensure that the reference number is placed after the punctuation, and not before. e.g. It
is widely used on automated haematology analysers in the form of Bull's algorithm.3
- List all authors when six or fewer; when seven or more, list the first six and add et al.
- Provide the date websites were accessed (see example below).
Examples:
- More than six authors
- Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JD, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res 2002;935:40-6.
- Standard journal article
- Gaw A, Hobbs HH. Molecular genetics of lipoprotein (a): new pieces to the puzzle. Curr Opin Lipidol 1994;5:149-55.
- Chapter in a book
- Lai MMC, Holmes KV. Coronaviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields Virology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. pp. 1163-86.
- Conference paper
- Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.
- Abstract
- Levy GA, Lake JR, Beauregard-Zollinger L, Prestele H. Improved clinical outcomes for liver transplant recipients using cyclosporine blood level monitoring based on two-hour post-dose levels (abstract). Transplantation 2000;69(Suppl):S387.
- Homepage/Website
- Centers for Disease Control and Prevention. In the absence of SARS-CoV transmission worldwide: guidance for surveillance, clinical and laboratory evaluation, and reporting version 2. http://www.cdc.gov/ncidod/sars/guidance/index.htm (Accessed 21 January 2004).
- Personal communications and unpublished papers are not acceptable citations in the
References. Instead, indicate appropriately in text in parentheses: for example, (Smith RX, personal communication).
- Use a separate page for each table.
- Give each table a title and number (Arabic numerals, bold face). A table title should
describe concisely the content of the table without reference to the text (no bold face).
- Provide a footnote to each table identifying all abbreviations used even if explained in
text. In footnotes, use the following symbols in sequence: *, †, ‡, §, ||, ¶, **, ††, ‡‡, §§,
||||, ¶¶, etc.
- Include copyright permission if table has been reproduced.
Author Form
The Assignment of Copyright and Declaration of Interest form must be completed and signed by all authors for each article and either uploaded with the manuscript at the time of submission or e-mailed to the Editor.
Download Form